Dabrafenib Recruiting Phase 1 / 2 Trials for Melanoma Treatment

Indications	Status	Purpose	Phase
DBCOND0020306 (Melanoma)	Recruiting	Treatment	1 / 2

clinicaltrials.gov Identifier	Title	Drugs
NCT03272464	INCB039110 in Combination With Dabrafenib and Trametinib in Patients With BRAF-mutant Melanoma and Other Solid Tumors.	Dabrafenib (DB08912) Trametinib (DB08911) Itacitinib (DB12154)
NCT03026517	Clinical Trial of Phenformin in Combination With Dabrafenib and Trametinib for Patients With BRAF-mutated Melanoma	Trametinib (DB08911) Dabrafenib (DB08912) Phenformin (DB00914)